CD6 is a target for cancer immunotherapy
Jeffrey H. Ruth(Center for Rheumatology), David A. Fox(University of Michigan)
Cited by 51
Related Papers
CXCL16‐mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway
|Arthritis & Rheumatism|2006|111
Evidence That CXCL16 Is a Potent Mediator of Angiogenesis and Is Involved in Endothelial Progenitor Cell Chemotaxis: Studies in Mice With K/BxN Serum–Induced Arthritis
|Arthritis & Rheumatism|2013|81
Inflammatory properties of inhibitor of DNA binding 1 secreted by synovial fibroblasts in rheumatoid arthritis
|Arthritis Research & Therapy|2016|32
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells
|Cancer Immunology Immunotherapy|2024|9